協鑫科技(03800.HK)完成配售合共15.6億股股份 淨籌15.3億港元
格隆匯1月6日丨協鑫科技(03800.HK)發佈公吿,有關配售最多15.6億股公司股份(“配售事項”)。配售事項於2025年1月3日完成。合共15.6億股股份(相當於經配發及發行配售股份擴大後已發行股本總額約5.48%)已配售予不少於六名承配人。
配售事項的所得款項淨額預計約為15.3億港元。所得款項淨額總額15.3億港元中,約9.4億港元已由公司於2025年1月3日收取,而約5.9億港元仍存放於配售代理的賬户內,連同自2025年1月3日起至公司實際收款日(預計為2025年1月6日)期間所產生的利息,待轉撥予公司。配售事項的所得款項淨額將主要用作下列用途:(i)約60%(即約9.2億港元)用作集團資本性支出,以發展及擴展集團的太陽能相關業務;及(ii)約40%(即約6.1億港元)將預留作一般營運資金用途,以促進集團的營運活動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.